Market watchers view mergers and acquisitions as an economic yardstick. After several years of modest volumes, we've already seen substantial M&A activity in 2014 across industries including biotech, pharmaceuticals, and technology. Has the market rediscovered its mojo? Our panel from Silicon Valley and San Francisco discusses the forces driving the recent upturn in deal volume, as well as talking about trends in shareholder activism, and current patterns in pre- Series A tech acquisitions. California Lawyer met for an update with David A. Lipkin of Morrison & Foerster; Michael Kennedy of Shearman & Sterling; Dana Kromm of Shearman & Sterling; and E. Thom (Todd) Rumberger of Foley & Lardner. The roundtable was moderated by California Lawyer and reported by Cherree P. Peterson of Barkley Court Reporters.
MODERATOR: Mergers and acquisitions have seen a significant uptick in the first quarter of 2014; what's driving this?
Originally published in California Lawyer on June 7, 2014.
Please see full article below for more information.
Firefox recommends the PDF Plugin for Mac OS X for viewing PDF documents in your browser.
We can also show you Legal Updates using the Google Viewer; however, you will need to be logged into Google Docs to view them.
Please choose one of the above to proceed!
LOADING PDF: If there are any problems, click here to download the file.
Topics: Biotechnology, Hedge Funds, Pharmaceutical, Poison Pill, Shareholder Activism, Shareholders, Silicon Valley, Technology, Valuation
Published In: General Business Updates, Finance & Banking Updates, Mergers & Acquisitions Updates, Science, Computers & Technology Updates, Securities Updates
DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.
© Morrison & Foerster LLP | Attorney Advertising